CVKD
Price
$12.35
Change
-$1.04 (-7.77%)
Updated
Jun 20 closing price
Capitalization
24.52M
47 days until earnings call
RAPP
Price
$10.92
Change
-$0.11 (-1.00%)
Updated
Jun 20 closing price
Capitalization
398.55M
47 days until earnings call
Interact to see
Advertisement

CVKD vs RAPP

Header iconCVKD vs RAPP Comparison
Open Charts CVKD vs RAPPBanner chart's image
Cadrenal Therapeutics
Price$12.35
Change-$1.04 (-7.77%)
Volume$15.06K
Capitalization24.52M
Rapport Therapeutics
Price$10.92
Change-$0.11 (-1.00%)
Volume$104.16K
Capitalization398.55M
CVKD vs RAPP Comparison Chart in %
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. RAPP commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (CVKD: $12.47 vs. RAPP: $10.92)
Brand notoriety: CVKD and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 70% vs. RAPP: 61%
Market capitalization -- CVKD: $24.52M vs. RAPP: $398.55M
CVKD [@Biotechnology] is valued at $24.52M. RAPP’s [@Biotechnology] market capitalization is $398.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, both CVKD and RAPP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 3 TA indicator(s) are bullish while RAPP’s TA Score has 5 bullish TA indicator(s).

  • CVKD’s TA Score: 3 bullish, 4 bearish.
  • RAPP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а -10.03% price change this week, while RAPP (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 07, 2025.

RAPP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($399M) has a higher market cap than CVKD($24.5M). CVKD YTD gains are higher at: -14.769 vs. RAPP (-38.444). CVKD has higher annual earnings (EBITDA): -12.82M vs. RAPP (-92.14M). RAPP has more cash in the bank: 285M vs. CVKD (7.34M). CVKD has less debt than RAPP: CVKD (0) vs RAPP (7.84M). CVKD (0) and RAPP (0) have equivalent revenues.
CVKDRAPPCVKD / RAPP
Capitalization24.5M399M6%
EBITDA-12.82M-92.14M14%
Gain YTD-14.769-38.44438%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.34M285M3%
Total Debt07.84M-
TECHNICAL ANALYSIS
Technical Analysis
CVKDRAPP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
86%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEPSX13.82-0.01
-0.07%
JPMorgan Equity Premium Income R5
NSFFX11.62-0.02
-0.17%
Natixis Target Retirement 2030 N
VNSCX19.23-0.05
-0.26%
Natixis Vaughan Nelson Select C
CVGCX14.05-0.07
-0.50%
Calamos Growth C
JSPJX20.45-0.14
-0.68%
Jackson Square Large-Cap Growth Inv

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-7.77%
MNPR - CVKD
29%
Poorly correlated
-0.42%
GDTC - CVKD
29%
Poorly correlated
-2.15%
WHWK - CVKD
25%
Poorly correlated
+1.95%
RAPP - CVKD
23%
Poorly correlated
-1.00%
LQDA - CVKD
23%
Poorly correlated
-3.45%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with CELC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
-1.00%
CELC - RAPP
42%
Loosely correlated
-1.78%
ABSI - RAPP
39%
Loosely correlated
+1.45%
NUVB - RAPP
38%
Loosely correlated
N/A
MNMD - RAPP
38%
Loosely correlated
-0.56%
ATAI - RAPP
37%
Loosely correlated
+6.44%
More